DISSEQ: Double-blind Next-Generation-Sequencing technologies (exome and gene panel) in the diagnosis of a cohort of 330 patients with an intellectual disability: concordance, discrepancies, and efficiencies

MLA

Bruel, A., et al. DISSEQ: Double-Blind Next-Generation-Sequencing Technologies (Exome and Gene Panel) in the Diagnosis of a Cohort of 330 Patients with an Intellectual Disability: Concordance, Discrepancies, and Efficiencies. Dec. 2020. EBSCOhost, https://doi.org/10.1038/s41431-020-00739-z⟩.

APA

Bruel, A., Gerard, B., Piton, A., Mau-Them, F. T., Sorlin, A., Sorly, A., Lacombe, D., Manouvrier, S., Edery, P., Philip, N., Genevieve, D., Verloes, A., Odent, S., Thevenon, J., Toutain, A., Bonneau, D., El Chehadeh, S., Doco-Fenzy, M., Isidor, B., … Thauvin-Robinet, C. (2020). DISSEQ: Double-blind Next-Generation-Sequencing technologies (exome and gene panel) in the diagnosis of a cohort of 330 patients with an intellectual disability: concordance, discrepancies, and efficiencies. https://doi.org/10.1038/s41431-020-00739-z⟩

Chicago

Bruel, A., B. Gerard, A. Piton, F. Tran Mau-Them, A. Sorlin, A. Sorly, D. Lacombe, et al. 2020. “DISSEQ: Double-Blind Next-Generation-Sequencing Technologies (Exome and Gene Panel) in the Diagnosis of a Cohort of 330 Patients with an Intellectual Disability: Concordance, Discrepancies, and Efficiencies,” December. doi:10.1038/s41431-020-00739-z⟩.